Ipilimumab (Yervoy) is an antibody inhibitor that blocks the inhibitory receptor cytotoxic T-lymphocyte antigen-4 (CTLA-4) on T cells, with immune-activating properties. Used for the treatment of unresectable or metastatic melanoma, this antibody exhibits antitumor activity.
Purity:
95.90%
CAS Number:
[477202-00-9]
Target:
Others|||Immunology/Inflammation related
T9906
T9906
* VAT and and shipping costs not included. Errors and price changes excepted
